Privia Health Group Inc
NASDAQ:PRVA
Privia Health Group Inc
NASDAQ:PRVA
Price:
21.73
USD
-1.54%
Market Closed
Market Cap:
$2.7B
Relative Value
The Relative Value of one
PRVA
stock under the Base Case scenario is
24.78
USD.
Compared to the current market price of 21.73 USD,
Privia Health Group Inc
is
Undervalued by 12%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PRVA
Relative Value
Base Case
24.78
USD
Undervaluation 12%
Multiples Across Competitors
PRVA Competitors Multiples
Privia Health Group Inc Competitors
Privia Health Group Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Privia Health Group Inc
NASDAQ:PRVA
|
2.7B USD | 1.2 | 115.1 | 48.9 | 63.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
96.7B USD | 0.2 | 54.7 | 14 | 14 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
67.3B EUR | 0.3 | 13.1 | 7.7 | 9.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
70B USD | 0.3 | 11.8 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.1B EUR | 1.2 | 20.9 | 9.8 | 14.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 1.2 | 23.6 | 9.1 | 16.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.1B USD | 2 | 22.4 | 12.4 | 16.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.6B USD | 1.5 | 24.6 | 11.9 | 17.3 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 0.6 | 11.3 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11B USD | 11.2 | -26.4 | -28.4 | -25.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.5B USD | 0.8 | 14 | 7.3 | 9.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
